Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Why This Trader Says Johnson & Johnson Stock Could Hit $300 In 2022

From consumer health to medtech to pharmaceuticals, the latest stock I'm analyzing is a brand name you will be no stranger to, particularly due to its COVID-19 efforts.  This company's heritage spans over 130 years, boasting trailblazing scientists and innovation that has been at the forefront of safeguarding global public health. 

JNJ